Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
17.76
-0.14 (-0.78%)
Feb 13, 2026, 4:00 PM EST - Market closed
Aktis Oncology Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$30.00
Upside
+68.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +68.92% | Feb 3, 2026 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $2 → $1 | Buy → Hold | Downgrades | $2 → $1 | -94.37% | Jan 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $6 → $3 | Buy | Maintains | $6 → $3 | -83.11% | Sep 7, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy → Hold Downgrades $9.25 → $1.75 | Strong Buy → Hold | Downgrades | $9.25 → $1.75 | -90.15% | Sep 7, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | -66.22% | May 9, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | -71.85% | May 9, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $9.25 | Strong Buy | Initiates | $9.25 | -47.92% | Jan 24, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | -60.59% | Nov 15, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | -71.85% | Sep 13, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $7 | Buy | Maintains | $11 → $7 | -60.59% | May 3, 2022 |
| Oppenheimer | Oppenheimer | Buy Maintains $18 → $13 | Buy | Maintains | $18 → $13 | -26.80% | Nov 2, 2021 |
| Roth Capital | Roth Capital | Strong Buy Maintains $25 → $16 | Strong Buy | Maintains | $25 → $16 | -9.91% | May 4, 2021 |
| Roth Capital | Roth Capital | Strong Buy Maintains $12 → $16 | Strong Buy | Maintains | $12 → $16 | -9.91% | Jan 4, 2021 |
| Northland Capital Markets | Northland Capital Markets | Hold Maintains $7.4 → $7 | Hold | Maintains | $7.4 → $7 | -60.59% | Dec 20, 2019 |
| Northland Capital Markets | Northland Capital Markets | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 18, 2019 |
| Northland Capital Markets | Northland Capital Markets | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 10, 2019 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.